Morgan Stanley’s Eloxx Pharmaceuticals ELOX Stock Holding History
Bought
Maintained
Sold
Other funds holding ELOX
SL
Morgan Stanley's ELOX Position: Q3 2026 in Review
Morgan Stanley increased its Eloxx Pharmaceuticals (ELOX) stake by 13,024% in Q3 2026, buying an estimated $3.11M and bringing the position to 202,630 shares worth $3.1M. The position accounts for ﹤0.01% of the portfolio, ranked #4608.
Morgan Stanley first reported a position in ELOX in Q2 2026 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold ELOX as of Q3 2026.
- Morgan Stanley held 202,630 shares of Eloxx Pharmaceuticals worth $3.1M as of Q3 2026.
- Morgan Stanley bought 201,086 Eloxx Pharmaceuticals shares in Q3 2026, an estimated $3.11M.
- Eloxx Pharmaceuticals made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #4608 holding.
- Morgan Stanley first reported a position in Eloxx Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- 20 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals as of Q3 2026.
Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.